ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

FBIOP Fortress Biotech Inc

15.87
0.26 (1.67%)
31 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Fortress Biotech Inc FBIOP NASDAQ Acción Preferente
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.26 1.67% 15.87 15:41:08
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
15.55 15.50 15.88 15.87 15.61
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
31/5/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202417:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/5/202415:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
31/5/202415:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
31/5/202415:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/5/202416:16EDGAR2Form 8-K - Current report
29/5/202416:04EDGAR2Form S-3/A - Registration statement under Securities Act of..
20/5/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202416:13EDGAR2Form SC 13D/A - General statement of acquisition of..
17/5/202416:01EDGAR2Form S-3 - Registration statement under Securities Act of..
17/5/202412:15EDGAR2Form 144 - Report of proposed sale of securities
15/5/202415:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202415:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202415:07EDGAR2Form 8-K - Current report
03/1/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:10EDGAR2Form 8-K - Current report
22/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202316:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/11/202316:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/10/202315:50EDGAR2Form 8-K - Current report
10/10/202315:24EDGAR2Form 8-K - Current report
29/9/202315:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/9/202315:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/9/202315:16EDGAR2Form SC 13D/A - General statement of acquisition of..
26/9/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202316:08EDGAR2Form SC 13D/A - General statement of acquisition of..
12/9/202308:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202308:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/8/202308:00EDGAR2Form DEF 14A - Other definitive proxy statements
15/8/202316:22EDGAR2Form PRE 14A - Other preliminary proxy statements
14/8/202315:08EDGAR2Form 8-K - Current report
06/7/202315:44EDGAR2Form SC 13D/A - General statement of acquisition of..
03/7/202312:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..